LIN SUE-JEAN

ARQT

LIN SUE-JEAN serves as Director at Arcutis Biotherapeutics, Inc. (ARQT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$778.0K

Net Position

Net Seller

$778.0K

Companies Traded

ARQT

Active Period

Nov 2025

1 total trades

Most Recent

Sell ARQT

Nov 24, 2025 · $778.0K

LIN SUE-JEAN's Insider Trading at Arcutis Biotherapeutics, Inc. (ARQT)

Buys

0 · $0.00

Sells

1 · $778.0K

Total Shares Bought

Total Shares Sold

25,272

ARQT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 24, 2025↗	Sell	25,272	$30.78	$778.0K	0

Related Insiders

Howard G. Welgus

director

ARQTSell · Mar 2, 2026

Todd Watanabe

director, officer: See Remarks

ARQTSell · Mar 2, 2026

Patrick Burnett

officer: See Remarks

ARQTSell · Mar 2, 2026

Latha Vairavan

officer: SVP Chief Financial Officer

ARQTSell · Mar 2, 2026

Larry Todd Edwards

officer: See Remarks

ARQTSell · Mar 2, 2026

Masaru Matsuda

officer: See Remarks

ARQTSell · Mar 2, 2026

Keith R Leonard

director

ARQTSell · Mar 2, 2026

Patrick Burnett

See Remarks

ARQTSell · Feb 4, 2026

Explore More Insider Trading Data

ARQT Insider Trading Activity

View all insider trades at Arcutis Biotherapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity